Frequently asked questions Can GLP-1 medications prevent breast cancer
This evolution in treatment highlights an urgent need for evidence that moves beyond weight loss alone to examine long-term cardiometabolic health, quality of life, and durability of treatment effects. Concerns about youth on GLP-1 According to Messiah, GLP-1 medications have demonstrated meaningful benefits for adolescents living with obesity, including substantial weight reduction and improvements in obesity-related conditions such as type 2 diabetes and hypertension, but she underscores that drugs need to be prescribed appropriately and accompanied by ongoing medical supervision
Vaccines (Basel) 9 , 326 (2021)
Effetti collaterali di Mounjaro Disturbi gastrointestinali : nausea, vomito e diarrea sono tra gli effetti pi frequenti, soprattutto nelle prime settimane di trattamento Riduzione dellappetito : sebbene sia uno degli obiettivi del farmaco, in alcuni pazienti la diminuzione dellappetito pu risultare eccessiva, portando a stanchezza o debolezza Effetti sul sistema metabolico : alcuni pazienti possono sviluppare ipoglicemia, in particolare se il farmaco associato a trattamenti con insulina o altri antidiabetici Reazioni allergiche : in casi rari, Mounjaro pu causare reazioni cutanee o sistemiche
GLP-1s have been used to treat Type 2 Diabetes since 2005
Studies reveal that oral semaglutide weight loss trials demonstrate a reduced risk of major cardiovascular eventsincluding heart attack and strokein adults with obesity or overweight who have known cardiovascular disease